Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. VC
VC logo

VC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Visteon Corp (VC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
89.090
1 Day change
-1.27%
52 Week Range
129.100
Analysis Updated At
2026/03/13
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Visteon Corp (VC) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is currently underperforming due to weak financial performance, insider selling, and a lack of positive catalysts. While there is a chance for short-term price recovery, the long-term outlook is clouded by disappointing guidance and reduced analyst price targets. Holding off on investment until clearer positive signals emerge is recommended.

Technical Analysis

The technical indicators suggest a bearish trend. The MACD is negative and contracting, RSI is neutral at 27.492, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is currently trading near its S1 support level of 89.283, with resistance at 91.993.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
3

Positive Catalysts

  • NULL identified. No recent news or significant positive developments. Analysts note some potential for recovery in 2027, but this is speculative.

Neutral/Negative Catalysts

  • Insider selling has increased significantly, up 6958.69% over the last month.

  • Analysts have lowered price targets citing disappointing 2026 guidance, reduced sales expectations, and program cancellations.

  • Weak financial performance in Q4 2025, with net income and EPS dropping over 90% YoY.

Financial Performance

In Q4 2025, revenue increased slightly by 0.96% YoY to $948 million. However, net income dropped by 90.28% YoY to $14 million, EPS fell by 90.12% YoY to 0.51, and gross margin declined by 9.81% to 12.87%. Overall, the financial performance indicates significant challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets across the board, with JPMorgan reducing its target to $110 from $118 and maintaining a Neutral rating. Other firms like Baird, RBC Capital, Deutsche Bank, UBS, and TD Cowen have also reduced targets but maintain mixed ratings ranging from Neutral to Buy. Analysts cite disappointing 2026 guidance and reduced sales expectations as key reasons for the downgrades.

Wall Street analysts forecast VC stock price to rise
10 Analyst Rating
Wall Street analysts forecast VC stock price to rise
6 Buy
4 Hold
0 Sell
Moderate Buy
Current: 90.240
sliders
Low
114
Averages
134.67
High
148
Current: 90.240
sliders
Low
114
Averages
134.67
High
148
JPMorgan
Neutral
downgrade
$118 -> $110
AI Analysis
2026-03-09
New
Reason
JPMorgan
Price Target
$118 -> $110
AI Analysis
2026-03-09
New
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Visteon to $110 from $118 and keeps a Neutral rating on the shares. The firm reduced estimates citing the company's "mixed" Q4 results. Visteon issued a "disappointing" 2026 outlook due to the cancelation of programs at key customer Ford, the non-repeat of various commercial items and customer recoveries that benefitted 2025, and by an anticipated 50% plunge in sales of its Battery Management Systems, the analyst tells investors in a research note.
Baird
Outperform
downgrade
$126 -> $119
2026-02-20
Reason
Baird
Price Target
$126 -> $119
2026-02-20
downgrade
Outperform
Reason
Baird lowered the firm's price target on Visteon to $119 from $126 and keeps an Outperform rating on the shares. The firm updated its model following Q4 results which justifis the firm's near-term cautious stance.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for VC
Unlock Now

People Also Watch